Published in J Clin Endocrinol Metab on May 01, 1995
Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease. J Thyroid Res (2012) 1.19
Development and evaluation of a model-based downscatter compensation method for quantitative I-131 SPECT. Med Phys (2011) 1.13
Predictors of thyroid tumor aggressiveness. West J Med (1996) 1.06
Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist (2010) 1.00
Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer. World J Surg (2004) 0.94
Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer. Thyroid (2013) 0.88
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence. Eur J Nucl Med Mol Imaging (2007) 0.87
Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg (2004) 0.86
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study. BMC Cancer (2014) 0.85
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging (2007) 0.85
Clinical significance of p53 protein expression in papillary thyroid carcinoma. World J Surg (2008) 0.84
Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab (1995) 0.84
Practice trends in patients with persistent detectable thyroglobulin and negative diagnostic radioiodine whole body scans: a survey of American Thyroid Association members. Thyroid (2014) 0.83
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. Eur J Nucl Med Mol Imaging (2005) 0.82
Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol (2003) 0.82
Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin. Acta Otorhinolaryngol Ital (2005) 0.81
Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? Br J Cancer (2004) 0.81
Advances in the follow-up of differentiated or medullary thyroid cancer. Nat Rev Endocrinol (2012) 0.80
To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients. J Oncol (2012) 0.79
Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up. Eur J Nucl Med Mol Imaging (2010) 0.79
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases. Eur J Nucl Med Mol Imaging (2004) 0.76
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans? Thyroid (2014) 0.76
Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer? Eur Thyroid J (2016) 0.75
Challenges of thyroid cancer management in amiodarone-treated patients: a case report. Clujul Med (2015) 0.75
Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy. Anticancer Res (2009) 0.75
Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy. Cancer Gene Ther (2016) 0.75
Management of thyroid cancers. Indian J Surg Oncol (2010) 0.75
The role of nuclear medicine in differentiated thyroid cancer. Wien Med Wochenschr (2012) 0.75
Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy. Eur J Nucl Med Mol Imaging (2016) 0.75
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol (1995) 7.28
Single-chain antigen-binding proteins. Science (1988) 5.29
Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem (1991) 4.45
Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem (1991) 4.34
Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol Biol Cell (1992) 4.17
Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition. Nature (2001) 3.92
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc (2000) 3.48
Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron (2001) 3.37
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12
Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS Collaborative Research Group. J Am Geriatr Soc (1994) 3.05
The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J Cell Biol (1988) 2.85
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
Brownian dynamics of cytochrome c and cytochrome c peroxidase association. Science (1988) 2.78
Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol (1995) 2.78
The effect of ethnicity on physician estimates of pain severity in patients with isolated extremity trauma. JAMA (1994) 2.77
The Pumilio RNA-binding domain is also a translational regulator. Mol Cell (1998) 2.68
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63
Thermodynamic analysis of the folding of the streptococcal protein G IgG-binding domains B1 and B2: why small proteins tend to have high denaturation temperatures. Biochemistry (1992) 2.56
Observations of fouling biofilm formation. Can J Microbiol (1981) 2.56
Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res (2001) 2.51
Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51
Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science (2012) 2.48
Cardiac physiology in transgenic mice. Circ Res (1998) 2.47
Genomic imprinting in an Angelman and Prader-Willi translocation family. Lancet (1991) 2.41
Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol (2001) 2.40
Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science (1998) 2.39
Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res (2000) 2.38
Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34
Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study. Osteoporos Int (2008) 2.27
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Cloning and sequencing of a putative Escherichia coli [NiFe] hydrogenase-1 operon containing six open reading frames. J Bacteriol (1990) 2.20
The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia (2000) 2.18
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18
Age effects on the temporal evolution of isometric and swallowing pressure. J Gerontol A Biol Sci Med Sci (2000) 2.15
Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res (1996) 2.05
Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg (1996) 2.03
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99
Impact of inter-physician communication on the effectiveness of medical consultations. Am J Med (1983) 1.98
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95
Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2006) 1.93
Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med (1999) 1.92
Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1997) 1.88
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A (1989) 1.85
A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods (1999) 1.84
Mouse model of desmin-related cardiomyopathy. Circulation (2001) 1.84
Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy. Circ Res (2001) 1.83
High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr (1998) 1.82
Characterization of Torpedo californica acetylcholine receptor: its subunit composition and ligand-binding properties. Cold Spring Harb Symp Quant Biol (1976) 1.81
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol (1994) 1.74
Apolipoprotein J: structure and tissue distribution. Biochemistry (1990) 1.73
Extent of Barrett's metaplasia: a prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging. Gastrointest Endosc (1997) 1.72
The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia (2000) 1.72
Mutational analysis and characterization of the Escherichia coli hya operon, which encodes [NiFe] hydrogenase 1. J Bacteriol (1991) 1.71
SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet (2005) 1.71
Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver. J Clin Invest (1972) 1.71
A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem (1981) 1.70
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch Phys Med Rehabil (2001) 1.68
Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem (2000) 1.66
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med (1993) 1.65
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.65
Structure-function relationships among the nickel-containing hydrogenases. FEMS Microbiol Rev (1992) 1.62
Predicting hospital choice for rural Medicare beneficiaries: the role of severity of illness. Health Serv Res (1991) 1.61
Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem (1984) 1.61
Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol (2000) 1.60
Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth (2006) 1.60
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer. J Clin Endocrinol Metab (2006) 1.60
Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem (1999) 1.60
Ten commandments for effective consultations. Arch Intern Med (1983) 1.59
Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. J Mol Cell Cardiol (2001) 1.59
Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57
Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem (1991) 1.56
Estimation of body fatness by air displacement plethysmography in African American and white children. Pediatr Res (2001) 1.55
Cloned genomic DNA sequences from Mycoplasma hyorhinis encoding antigens expressed in Escherichia coli. Proc Natl Acad Sci U S A (1983) 1.54
The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem (2001) 1.53
DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res (1998) 1.53
Hallux valgus assessment: report of research committee of American Orthopaedic Foot and Ankle Society. Foot Ankle (1984) 1.52
Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52
Immune response to blood transfusion invery-low-birthweight infants. Transfusion (2000) 1.51
Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc (2001) 1.51
In vivo analysis of the murine beta-myosin heavy chain gene promoter. J Biol Chem (1993) 1.50
Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol (2013) 1.49
Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res (2000) 1.49
A case of tetramine poisoning: a lethal rodenticide. Hong Kong Med J (2005) 1.49
High diversity and widespread occurrence of mitotic spore mats in ectomycorrhizal Pezizales. Mol Ecol (2012) 1.49
Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism. J Cell Biol (1991) 1.48
Papillary endothelial hyperplasia in the thyroid following fine-needle aspiration. Arch Pathol Lab Med (1991) 1.46
Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J Clin Invest (2001) 1.46
In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation. J Biol Chem (1993) 1.45
The isolation and partial characterization of recombinant DNA containing genomic globin sequences from the goat. J Biol Chem (1979) 1.44
Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr (2001) 1.43